학술논문
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
Document Type
Article
Author
Price, Gillian; Shaw, Paul; Cave, Judith; Naik, Jay; Ford, Amy; Geldhart, Tom; Dancey, Gairin; Papadatos, Dionysis; Polychronis, Andy; Jankowska, Petra; Scott, Angela; Gardiner, Jill; Cominos, Mathilda; Campbell, Lynn; MacGregor, Carol; Mullholand, Lois; Chitnis, Meenali; Dougherty, Gary; Fennell, Dean A ; Ewings, Sean; Ottensmeier, Christian; Califano, Raffaele; Hanna, Gerard G; Hill, Kayleigh; Danson, Sarah; Steele, Nicola; Nye, Mavis; Johnson, Lucy; Lord, Joanne; Middleton, Calley; Szlosarek, Peter; Chan, Sam; Gaba, Aarti; Darlison, Liz; Wells-Jordan, Peter; Richards, Cathy; Poile, Charlotte; Lester, Jason F; Griffiths, Gareth
Source
In The Lancet Oncology November 2021 22(11):1530-1540
Subject
Language
ISSN
1470-2045